Annotation Detail

Information
Associated Genes
EGFR
Associated Variants
EGFR MUTATION
EGFR MUTATION
Associated Disease
lung adenocarcinoma
Source Database
CIViC Evidence
Description
In a study of 1036 patients with lung adenocarcinomas, patients with EGFR mutations (n=275) showed better prognosis (OS: 34 months versus 23 months; HR=0.6; P<0.001).
Variant Origin
somatic
Variant Origin
Somatic
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/1701
Gene URL
https://civic.genome.wustl.edu/links/genes/19
Variant URL
https://civic.genome.wustl.edu/links/variants/442
Rating
4
Evidence Type
Prognostic
Disease
Lung Adenocarcinoma
Evidence Direction
Supports
Evidence Level
B
Clinical Significance
Better Outcome
Pubmed
22810899
Drugs